Expenditure Analysis of Two Year Payer Costs of Commercially Insured Type 2 Diabetes Patients Identified as Receiving Multiple Daily Injections (MDI) or Insulin Pump Therapy (CSII) Stratified by Related Diagnosis
Value in Health - United Kingdom
doi 10.1016/j.jval.2014.03.1429
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2014
Authors
Publisher
Elsevier BV